# OrphaFold Architecture: Multi-Agent Structural Intelligence

OrphaFold utilizes an agentic orchestration pipeline designed to bridge the gap between clinical data, literature research, and structural proteomics.

## ğŸ—ï¸ System Overview

The system architecture is divided into three distinct layers:
1. **Pre-Flight Enrichment Layer** (Data Grounding)
2. **Logic Engine** (Gemini 3 Orchestration)
3. **Execution Layer** (Specialized Agents)

```mermaid
graph TD
    A[User Query] --> B[Pre-Flight Enrichment]
    subgraph "Data Enrichment (REST APIs)"
        B --> B1[Orphanet]
        B --> B2[UniProt]
        B --> B3[PubMed]
        B --> B4[OMIM/ClinVar/Gene]
    end
    B1 & B2 & B3 & B4 --> C[Gemini 3 Orchestrator]
    subgraph "Specialized Agents"
        C --> D[Clinical Agent]
        C --> E[Bio-Mechanism Agent]
        C --> F[Discovery Agent]
        C --> G[Hypothesis Lab]
    end
    D & E & F & G --> H[Structured Research Report]
    H --> I[3D AlphaFold Viewer]
```

---

## ğŸ›¡ï¸ 1. Pre-Flight Enrichment Layer
Before any AI reasoning occurs, the system performs a "Pre-Flight" sweep across trusted biomedical databases. This creates a **Grounded Context** that eliminates hallucinations.
- **Orphanet/OMIM**: For disease classification and validated medical IDs.
- **UniProt/NCBI Gene**: For mapping target proteins and genomic coordinates.
- **ClinVar**: For identifying pathogenic variants.
- **PubMed**: For retrieving the most recent clinical literature.

## ğŸ§  2. Gemini 3 Logic Engine
We utilize **Gemini 3** with a large context window and **Thinking Config (Thinking Budget)**. This allows the model to:
- Perform long-range reasoning over complex biological pathways.
- Use **Grounding with Google Search** to fill gaps in API data (e.g., very recent clinical trials).
- Maintain state across multiple specialized agents.

## ğŸ‘¥ 3. The 4 Specialized Agents

### ğŸ¥ Clinical Grounding Agent
Maps the epidemiological landscape. It synthesizes prevalence, inheritance patterns, and the hierarchical classification of the disease.

### ğŸ§ª Bio-Mechanism Agent
The "structural brain" of the system. It connects the disease to UniProt entries and retrieves **AlphaFold 3D protein structures** from AlphaFold DB API. It analyzes molecular functions, functional domains (Pfam/InterPro), and signaling pathways.

### ğŸ”¬ Discovery Agent
Scans the research landscape. It synthesizes literature reviews and maps active recruitment pipelines from ClinicalTrials.gov. It also handles **Cross-Disease Insights**, identifying shared mechanisms between rare and common pathologies.

### ğŸ’Š Hypothesis Lab (Repurposing Agent)
The synthesis catalyst. It uses structural homology analysis to identify existing drugs that target shared protein mechanisms, providing a feasibility score and a rationale for in-silico validation.

---

## âš¡ Structural Integration
The frontend integrates with the **AlphaFold DB API**, allowing the AI to direct the user to specific protein visualizations curated by the Bio-Mechanism agent.
